Open main menu
Blog HomeProductContact

Case Study

How Access CCT Went from Two Enrolled Patients to a Pipeline of 39 on a Trial a Year Behind Schedule

How Access CCT Went from Two Enrolled Patients to a Pipeline of 39 on a Trial a Year Behind Schedule

Access CCT was running a tough Phase 2/3 epilepsy trial that was over a year behind enrollment targets. They added HealthKey alongside an existing recruitment platform. HealthKey processed 996,044 medical records, identified 39 eligible patients from 5,608 screened, and found an additional patient who qualified — one their other platform missed completely.

How Flourish Research screened 11,041 patients across 4 clinics and enrolled for a novel obesity biologic in 25 days.

How Flourish Research screened 11,041 patients across 4 clinics and enrolled for a novel obesity biologic in 25 days.

Flourish Research needed to find patients for a first-in-class obesity biologic across 4 partner clinics running on different EHRs. HealthKey processed 4.2 million medical records, identified 323 eligible patients, and delivered the first enrollment in 25 days.

How Flourish Research Screened 12,004 Patients Across 6 Sites for a Phase 3 Obesity Trial Targeting GLP-1 Add-On Therapy.

How Flourish Research Screened 12,004 Patients Across 6 Sites for a Phase 3 Obesity Trial Targeting GLP-1 Add-On Therapy.

Flourish Research deployed HealthKey across six clinic sites to screen 12,004 patients and 4.6 million medical records for Eli Lilly's ENLIGHTEN-6 trial, identifying 23 eligible patients for a study requiring verification of stable GLP-1 therapy, BMI thresholds, and obesity-related comorbidities.

How Flourish Research Screened 4,269 Hypertension Patients and 364,607 medical records for a Global Cardiovascular Trial.

How Flourish Research Screened 4,269 Hypertension Patients and 364,607 medical records for a Global Cardiovascular Trial.

Flourish Research's Detroit site was the first in their network to deploy HealthKey for Alnylam's ZENITH trial. HealthKey screened 4,269 patients and 364,607 medical records against 24 eligibility criteria, saving an estimated 1,280 hours of manual chart review.

How HealthKey Screened Two Clinics in Parallel for a Phase 2 Bladder Cancer Trial.
OncologyUrology
•

How HealthKey Screened Two Clinics in Parallel for a Phase 2 Bladder Cancer Trial.

US Urology Partners' care navigation team couldn't scale to every location. HealthKey screened 1,452 patients and 859,000 medical records across two clinics simultaneously, finding eligible patients at each site and enrolling both for CG Oncology's CORE-008 trial.

"Will Not Be an Easy Protocol." How Tekton Went From a 42-Criteria Protocol to 14 Qualified Patients in 11 Days.
Rheumatology
•

"Will Not Be an Easy Protocol." How Tekton Went From a 42-Criteria Protocol to 14 Qualified Patients in 11 Days.

UCB's bimekizumab protocol had 42 eligibility criteria across two disease cohorts. Tekton Research used HealthKey to screen 650 patients and surface 14 qualified candidates in 11 days, 2.8x the enrollment target, for a trial the site couldn't have staffed manually.

How HealthKey found 16 Intermediate Risk Bladder Cancer patients in 1-Month for a Closing Bladder Cancer Trial.
OncologyDevice
•

How HealthKey found 16 Intermediate Risk Bladder Cancer patients in 1-Month for a Closing Bladder Cancer Trial.

US Urology Partners had one month before a J&J bladder cancer trial closed enrollment. HealthKey screened 431 patients and 353,000 medical records, found 16 with intermediate-risk NMIBC, and identified 2 eligible patients with 6 more staged for recurrence.

"I Was Doing This by Hand for a Year." How Tekton Research Cut RA Trial Chart Review by 97%.
Rheumatology
•

"I Was Doing This by Hand for a Year." How Tekton Research Cut RA Trial Chart Review by 97%.

Tekton’s Site Manager was manually screening 1,300 rheumatoid arthritis patient charts for a Merck Phase 2b trial. HealthKey processed 2,087 patients and 1.7 million medical records, narrowing her review to 40 charts and saving 626 hours.

How Oregon Urology Institute Found 6 PSMA-DC Patients in 1 Week (After Enrolling Zero for Two Years)
Oncology
•

How Oregon Urology Institute Found 6 PSMA-DC Patients in 1 Week (After Enrolling Zero for Two Years)

Oregon Urology Institute searched for eligible clinical trial patients for the Novartis PSMA-DC study for two years with zero enrollments. HealthKey processed 5.2 million medical records, identified 6 eligible patients, 3 consented, and 1 enrolled.

How Urology Centers of Alabama Screened 22,701 Patients and Found 68 Eligible for the eCoin Trial
UrologyDevice
•

How Urology Centers of Alabama Screened 22,701 Patients and Found 68 Eligible for the eCoin Trial

Urology Centers of Alabama struggled with manual chart review for the Valencia eCoin trial. HealthKey processed 2.4 million medical records, identified 68 eligible patients across 20 criteria, and enrolled 3 new patients within weeks.